Xu Kevin Y, Jones Hendrée E, Martin Caitlin E, Smid Marcela C, Tiako Max Jordan Nguemeni, Terplan Mishka, Krans Elizabeth E
Health & Behavior Research Center, Division of Addiction Science, Prevention, and Treatment, Department of Psychiatry, Washington University School of Medicine, Saint Louis, MO (KYX); Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, NC (HEJ); Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, Richmond, VA (CEM); Department of Obstetrics and Gynecology, University of Utah School Health, Salt Lake City, UT (MCS); Department of Medicine, UCLA Geffen School of Medicine, Los Angeles, CA (MJNT); Friends Research Institute, Baltimore, MD (MT); and Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Women's Research Institute, Pittsburgh, PA (EEK).
J Addict Med. 2025;19(4):470-474. doi: 10.1097/ADM.0000000000001438. Epub 2025 Feb 17.
Substance use is a leading cause of pregnancy-associated death in the US. It is not known if the amount of perinatal content at national addiction science conferences reflects the research and education being done in this area nationally.
We analyzed oral presentation sessions at five major addiction scientific conferences from 2021 to 2023 (American Academy of Addiction Psychiatry [AAAP], American Society of Addiction Medicine [ASAM], Association for Multidisciplinary Education and Research in Substance use and Addiction [AMERSA], College on Problems of Drug Dependence [CPDD], Research Society on Alcohol [RSA]) closely affiliated with organizations involved with substance use-related research and funding. Conference programs were searched using an inductive framework to identify sessions focused on pregnancy or the postpartum period. Available session materials were reviewed, coded, and categorized into three mutually exclusive groups: 1) dedicated to the perinatal period, 2) containing some perinatal content, but were not dedicated to the perinatal period, and 3) sessions with no perinatal content.
Across >3,000 speakers, less than 10% of sessions (76/788) contained perinatal substance use-related content. Among these, 4.7% (39/788) sessions were dedicated to the perinatal period, with the common topic covered being epidemiologic data on long-term infant neurodevelopmental outcomes following in utero drug exposure (n = 22). An additional 37 had some perinatal content but were not primarily focused on perinatal substance use. Among sessions dedicated to the perinatal period, only two covered overdoses.
Sessions dedicated to the perinatal period may not adequately reflect the diverse real-world needs of birthing people with substance use disorders. Whereas included sessions commonly covered neurodevelopmental outcomes (ie, fetal alcohol spectrum disorders), overdose and the postpartum period were seldom covered.
在美国，物质使用是与妊娠相关死亡的主要原因。目前尚不清楚全国成瘾科学会议上围产期相关内容的数量是否反映了该领域在全国范围内开展的研究和教育情况。
我们分析了2021年至2023年期间五个主要成瘾科学会议（美国成瘾精神病学学会[AAAP]、美国成瘾医学学会[ASAM]、物质使用与成瘾多学科教育与研究协会[AMERSA]、药物依赖问题学院[CPDD]、酒精研究学会[RSA]）的口头报告环节，这些会议与参与物质使用相关研究和资助的组织密切相关。使用归纳框架搜索会议议程，以确定专注于妊娠或产后时期的环节。对可用的会议材料进行审查、编码，并分为三个相互排斥的组：1）专门针对围产期，2）包含一些围产期内容，但并非专门针对围产期，3）没有围产期内容的环节。
在超过3000名演讲者中，不到10%的环节（76/788）包含围产期物质使用相关内容。其中，4.7%（39/788）的环节专门针对围产期，涵盖的常见主题是子宫内药物暴露后婴儿长期神经发育结局的流行病学数据（n = 22）。另外37个环节有一些围产期内容，但并非主要关注围产期物质使用。在专门针对围产期的环节中，只有两个涉及过量用药。
专门针对围产期的环节可能无法充分反映患有物质使用障碍的分娩人群的各种现实需求。虽然纳入的环节通常涵盖神经发育结局（即胎儿酒精谱系障碍），但过量用药和产后时期很少被涉及。
